Revelation Partners
Fred is the Managing Director, Head of Business Origination at Revelation Partners.
With over 14 years of banking and investment experience, Fred focuses on identifying and reviewing new investment opportunities, as well as managing the firm’s industry relationships. Fred is responsible for sourcing recent investments in Adaptive Biotechnologies, Omada Health, NeuroPace, SomaLogic, and Synthego.
Prior to Revelation Partners, Fred was a Managing Director in the Life Sciences Group at Bridge Bank, where he executed venture debt investments across all healthcare sectors. Fred began his career in the Healthcare Investment Banking group at Citi, where he advised on a number of M&A and financing transactions for both public and private healthcare clients.
Fred received a BS in Business Administration and BA in Economics from the University of California, Berkeley.
When not working with healthcare companies and investors, Fred enjoys running, playing basketball, and snowboarding. He lives in Orinda, California, with his wife and two young children.
Revelation Partners
Revelation Partners is a dedicated secondary investor in the healthcare space. We specialize in providing both CAPITAL and LIQUIDITY solutions to healthcare investors, companies, founders, and funds. Revelation Partners invests broadly across sectors, including medical devices, diagnostics, biopharmaceuticals, healthcare IT, and healthcare services. Leerink Revelation Partners ("LRP") is an investment partnership formed in 2015 through a strategic relationship with Leerink Capital Partners, the asset management affiliate of Leerink Partners. LRP manages $420 million across two funds, the most recent of which, a $228 million fund, began investing in early-2018.